Meni-Drops

Ketotifen hydrogen fumarate, the active ingredient in Meni-Drops, is an antihistamine (H1 receptor antagonist) presented as an ophthalmic solution for ocular use. It is used to relieve allergic eye symptoms such as itching, redness, and watery discharge in patients with allergic conjunctivitis.

GNH USA supplies Meni-Drops as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Meni-Drops, an ocular antihistamine, is indicated for allergic eye conditions that involve mast‑cell mediated inflammation.

Allergic conjunctivitis: reduces itching, redness and swelling of the conjunctiva. Ocular itching due to allergy: provides rapid relief of itch sensation. Eye redness from allergy: diminishes hyperemia and improves comfort.

Meni-Drops may cause local and systemic reactions, although many patients experience no adverse events.

Common Side Effects: - Transient burning or stinging on instillation. - Mild eye irritation or foreign‑body sensation. - Temporary blurred vision. - Mild conjunctival hyperemia. - Tearing or increased lacrimation. - Mild headache.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) with swelling of eyelids or face. - Persistent ocular inflammation or keratitis. - Significant visual disturbance. - Corneal ulceration. - Systemic hypersensitivity (rash, urticaria).

Before using Meni-Drops, consider the following safety measures.

Avoid use in patients with known hypersensitivity to ketotifen or any formulation excipient. Do not apply if the ocular surface is infected or severely inflamed without physician guidance. Monitor for signs of increased intra‑ocular pressure in glaucoma patients. Use with caution in pregnant or breastfeeding women; consult a healthcare professional. Store at ambient temperature: keep in the original container, protect from light and moisture.

Meni-Drops may interact with other ocular or systemic agents.

Major Interactions (Avoid): - Concurrent use of other topical antihistamines may increase local irritation. - Co‑administration with contact lens solutions containing preservatives can exacerbate ocular discomfort.

Moderate Interactions (Monitor Closely): - Systemic antihistamines may potentiate drowsiness if significant systemic absorption occurs. - Use with ocular decongestants may increase risk of rebound hyperemia. - Concurrent ophthalmic corticosteroids may mask signs of infection. - Interaction with MAO inhibitors is unlikely but monitor for unexpected systemic effects.